Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hubei Yibantian Pharmaceutical is a prominent Chinese pharmaceutical company specializing in the research, development, and manufacturing of high-end parenteral nutrition and clinical infusion products. Founded in 2011 and headquartered in Yingcheng, Hubei, the company has established itself as a leader in the domestic market for large-volume parenterals (LVP), including amino acid injections and fat emulsions. Its state-of-the-art manufacturing facilities are GMP-certified and utilize advanced automated production technologies to ensure high product quality. The company's portfolio targets critical therapeutic areas such as hepatology, nephrology, and cardiovascular health, with a focus on filling gaps in specialized intravenous therapies. Yibantian is recognized as a national high-tech enterprise and continues to expand its R&D capabilities through its dedicated research institute in Wuhan.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 湖北一半天制药.